Precept Study

Status

not recruiting iconNOT RECRUITING

Purpose

To look at how safe and effective CEP-1347 (Precept) is in patients with early Parkinson's disease. It measures the effect of Precept on Parkinson's disease by giving the patient Precept and then measuring the amount of time that passes before the patient needs standard Parkinson's disease medications to treat their symptoms. It also looks at the effect that Precept has on certain brain cells by using an investigational radioactive material called Y-CIT (beta-CIT).

Investigator(s)

Helen Bronte-Stewart